UBS ASSET MANAGEMENT AMERICAS LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$13,890,068,000
+55.2%
149,452
-0.6%
0.01%
+25.0%
Q3 2021$8,950,961,000
-15.0%
150,310
-2.7%
0.00%
-20.0%
Q2 2021$10,531,034,000
-2.7%
154,414
-1.1%
0.01%0.0%
Q1 2021$10,828,655,000
-64.5%
156,055
-60.7%
0.01%
-64.3%
Q4 2020$30,514,724,000
+148.3%
397,172
+141.7%
0.01%
+100.0%
Q3 2020$12,290,615,000
+23.8%
164,335
+4.2%
0.01%
+16.7%
Q2 2020$9,929,420,000
+326.5%
157,735
+184.5%
0.01%
+200.0%
Q1 2020$2,328,354,000
-7.1%
55,437
+0.4%
0.00%0.0%
Q4 2019$2,506,820,000
+2.2%
55,192
+3.0%
0.00%0.0%
Q3 2019$2,453,134,000
+3.2%
53,597
+32.3%
0.00%0.0%
Q2 2019$2,376,098,000
+42.1%
40,527
+8.6%
0.00%
+100.0%
Q1 2019$1,672,427,000
+20.1%
37,306
+4.3%
0.00%0.0%
Q4 2018$1,392,969,000
-5.5%
35,763
+11.7%
0.00%0.0%
Q3 2018$1,473,607,000
+5.6%
32,0210.0%0.00%0.0%
Q2 2018$1,396,115,000
+75.9%
32,021
+59.3%
0.00%0.0%
Q1 2018$793,793,000
+62.4%
20,096
+39.7%
0.00%
Q4 2017$488,693,00014,3860.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 139,528$6,083,0004.46%
Eversept Partners, LP 134,151$5,848,9842.68%
DAFNA Capital Management LLC 95,242$4,153,0001.94%
GREAT POINT PARTNERS LLC 302,000$13,167,0001.82%
Atika Capital Management LLC 190,000$8,284,0001.59%
Crawford Lake Capital Management, LLC 205,600$8,964,0001.57%
Crawford Lake Capital Management, LLC 205,688$8,968,0001.57%
Cormorant Asset Management, LP 450,000$19,620,0001.45%
SENZAR ASSET MANAGEMENT, LLC 11,123$485,0001.40%
Rhenman & Partners Asset Management AB 284,621$12,409,0001.27%
View complete list of ARENA PHARMACEUTICALS INC shareholders